
PFizer CEO Hints at Possible Relocation of Manufacturing Operations Outside the US by 2025
Pfizer’s Possible Shift in Manufacturing Amidst Tariff Threats In a recent development, Pfizer CEO Albert Bourla announced on Monday that the pharmaceutical giant might relocate its manufacturing operations to the United States, should the need arise, in response to the Trump administration’s threats of imposing numerous tariffs on imported goods. This announcement comes as part…